Latest News
Adding hyperimmune anti-coronavirus antibodies to treatment does not improve outcomes for adults in hospital with COVID-19
This is according to results from the ITAC trial, published today in The Lancet.
Adding hyperimmune anti-coronavirus antibodies to treatment does not improve outcomes for adults in hospital with COVID-19